Percentage of Institutions Within ±20% of North American Consensus Guidelines for Administered Radiopharmaceutical Activities in Children and Adolescents
| 2007 administered activity | 2013 administered activity | |||||
| Radiopharmaceutical | Based on weight only | Minimum | Maximum | Based on weight only | Minimum | Maximum |
| 18F-FDG | 83.3% (5/6) | 50.0% (3/6) | 91.7% (11/12) | 75.0% (9/12) | ||
| 99mTc-methylene diphosphate | 0.0% (0/8) | 15.4% (2/13) | 81.8% (9/11) | 50.0% (6/12) | ||
| 123I-metaiodobenzylguanidine | 85.7% (6/7) | 54.6% (6/11) | 84.6% (11/13) | 75.0% (9/12) | 75.0% (9/12) | 84.6% (11/13) |
| 99mTc-diisopropyl iminodiacetic acid | 14.3% (1/7) | 23.1% (3/13) | 70.0% (7/10) | 30.8% (4/13) | ||
| 99mTc-dimercaptosuccinic acid | 25.0% (2/8) | 0.0% (0/11) | 66.7% (8/12) | 0.0% (0/13) | ||
| 99mTc-NaTcO4 (for Meckel diverticulum) | 0.0% (0/7) | 8.3% (1/12) | 45.5% (5/11) | 38.5% (5/13) | ||
| 99mTc-mercaptoacetyltriglycine | 12.5% (1/8) | 41.7% (5/12) | 0.0% (0/13) | 30.0% (3/10) | 75.0% (9/12) | 50.0% (6/12) |
| 99mTc-macroaggregated albumin | 14.3% (1/7) | 0.0% (0/12) | 27.3% (3/11) | 58.3% (7/12) | ||